Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)

Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)

Authors of this article:

Carlos Rabade Castedo^{1, 2} ;   Ana Estany-Gestal³ ;   Carlos A Jiménez Ruiz⁴ ;   José Ignacio de Granda-Orive^{5, 6} ;   Juan Antonio Riesco-Miranda^{7, 8, 9} ;   María Isabel Cristóbal Fernández⁴ ;   Angela Ramos-Pinedo¹⁰ ;   Jaime Signes-Costa Miñana^{11, 12} ;   María Inmaculada Gorordo-Unzueta^{13, 14} ;   Agustin Valido-Morales¹⁵ ;   Jacobo Sellarés -Torres¹⁶ ;   Eva Cabrera-César¹⁷ ;   Alejandro Frino-García¹⁶ ;   Luis Valdés Cuadrado^{1, 2, 18}